Skip to main
MOH
MOH logo

Molina Healthcare (MOH) Stock Forecast & Price Target

Molina Healthcare (MOH) Analyst Ratings

Based on 32 analyst ratings
Buy
Strong Buy 25%
Buy 41%
Hold 28%
Sell 3%
Strong Sell 3%

Bulls say

Molina Healthcare Inc is experiencing positive momentum due to its expansion in the Medicaid sector, with contracts in 18 states poised to grow to 21 by 2024, contributing to its member base of 5.3 million across various programs. The company's strategic focus on higher utilization for long-term services, highlighted by its significant New Mexico contract estimated to generate $500 million in revenue, signals a robust growth opportunity. Furthermore, Molina's guidance for 2025 adjusted EPS at a minimum of $24.50 indicates a projected year-over-year growth of at least 8.2%, reflecting a solid financial outlook amidst an evolving market landscape.

Bears say

Molina Healthcare Inc. reported a fourth-quarter adjusted EPS of $5.05, which fell 14% short of market expectations, primarily due to a consolidated medical loss ratio (MLR) of 90.2%, reflecting an increase of 106 basis points year-over-year. The company's outlook is negatively impacted by potential risks associated with the expiration or reduction of Affordable Care Act (ACA) enhanced subsidies, which could significantly affect the profitability of its Marketplace segment. Additionally, elevated utilization levels in Medicare Advantage and other pressures on reimbursement contribute to ongoing MLR risks, casting doubt on Molina’s growth and profitability trajectory.

Molina Healthcare (MOH) has been analyzed by 32 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 41% recommend Buy, 28% suggest Holding, 3% advise Selling, and 3% predict a Strong Sell.

This aggregate rating is based on analysts' research of Molina Healthcare and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Molina Healthcare (MOH) Forecast

Analysts have given Molina Healthcare (MOH) a Buy based on their latest research and market trends.

According to 32 analysts, Molina Healthcare (MOH) has a Buy consensus rating as of Jul 2, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $266.25, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $266.25, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Molina Healthcare (MOH)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.